Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia

Circ Arrhythm Electrophysiol. 2015 Jun;8(3):748-50. doi: 10.1161/CIRCEP.115.002765.

¹ From the Department of Radiation Oncology (B.W.L., S.G.S., L.W., A.L., B.P.F., X.S.), Stanford Cancer Institute (B.W.L., S.G.S.), Department of Radiology, Division of Nuclear Medicine and Molecular Imaging (A.I.), and Department of Medicine (Cardiac Electrophysiology) (L.N., P.Z.), Stanford University School of Medicine, Stanford, CA; Cardiac Electrophysiology, Texas Cardiac Arrhythmia Institute, Austin, TX (A.A.-A.); and Department of Medical Affairs, CyberHeart, Inc., Portola Valley, CA (E.G., T.F., P.M.).
² From the Department of Radiation Oncology (B.W.L., S.G.S., L.W., A.L., B.P.F., X.S.), Stanford Cancer Institute (B.W.L., S.G.S.), Department of Radiology, Division of Nuclear Medicine and Molecular Imaging (A.I.), and Department of Medicine (Cardiac Electrophysiology) (L.N., P.Z.), Stanford University School of Medicine, Stanford, CA; Cardiac Electrophysiology, Texas Cardiac Arrhythmia Institute, Austin, TX (A.A.-A.); and Department of Medical Affairs, CyberHeart, Inc., Portola Valley, CA (E.G., T.F., P.M.). PaulZei@stanford.edu.

No abstract available

Keywords: ablation; cardiac electrophysiology; cardiomyopathy; ventricular tachycardia.

Publication types